The report presents a detailed analysis of the Epstein-Barr Virus (EBV) diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology are reviewed.
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
List of Tables
The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Blood Banks
- Physician Offices
- Public Health Labs
List of Tables
- Major Companies Developing or Marketing Epstein-Barr Virus (EBV) Tests
- France Epstein-Barr Virus (EBV) Test Volume and Diagnostics Sales Forecast by Market Segment
- Germany Epstein-Barr Virus (EBV) Test Volume and Diagnostics Sales Forecast by Market Segment
- Italy Epstein-Barr Virus (EBV) Test Volume and Diagnostics Sales Forecast by Market Segment
- Japan Epstein-Barr Virus (EBV) Test Volume and Diagnostics Sales Forecast by Market Segment
- Spain Epstein-Barr Virus (EBV) Test Volume and Diagnostics Sales Forecast by Market Segment
- U.K. Epstein-Barr Virus (EBV) Test Volume and Diagnostics Sales Forecast by Market Segment
- U.S.A. Epstein-Barr Virus (EBV) Test Volume and Diagnostics Sales Forecast by Market Segment
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako
